Keiler A, Salem G, Möschl P, Glöckler M
Arzneimittelforschung. 1977;27(12):2314-6.
In contrast with kidney, heart and liver transplantations, lung transplantation involves an organ which has contact with the environment and bears a special risk of infection. This circumstance and the diminished resistance during immunosuppressive therapy makes long-term treatment with an effective broad-spectrum antibiotic advisable for lung transplantations. Taking into consideration the different objectives and questions within the research project concerned the 182 lung allotransplantations carried out in dogs can be divided into two therapeutic groups in regard to postoperative treatment: lung allotransplantations with and without immunosuppressive therapy (methylprednisolone, azathioprine). Long-term doxycycline therapy was carried out in both groups. Those animals which were not treated with immunosuppressive drugs survived for an average of 9 days, those receiving immunosuppressive therapy survived for an average of 30 days. The longest survival period was 2.5 years. Clinically and histologically it could be demonstrated that doxycycline was successful both during the immediate postoperative period and in antibiotic long-term therapy after experimental lung transplantations.
与肾脏、心脏和肝脏移植不同,肺移植所涉及的器官与外界环境接触,存在特殊的感染风险。这种情况以及免疫抑制治疗期间抵抗力的下降使得对肺移植患者采用有效的广谱抗生素进行长期治疗是可取的。考虑到相关研究项目中的不同目标和问题,就术后治疗而言,在狗身上进行的182例同种异体肺移植可分为两个治疗组:接受免疫抑制治疗(甲基强的松龙、硫唑嘌呤)和未接受免疫抑制治疗的同种异体肺移植。两组均进行了长期强力霉素治疗。未接受免疫抑制药物治疗的动物平均存活9天,接受免疫抑制治疗的动物平均存活30天。最长存活期为2.5年。临床和组织学研究表明,强力霉素在实验性肺移植术后的即刻阶段以及抗生素长期治疗中均取得了成功。